Antithrombotic Drug with Low Risk of Bleeding
Exhibitor: CENTER FOR BIOMEDICAL RESEARCH AND DEVELOPMENT, NCKU
Booth No: N516
Characteristic
The current fibrinolytic therapy or percutaneous coronary intervention (PCI) needs to be combined with anti-platelet drugs for subsequent restenosis or recurrent thrombosis. Antithrombotic drugs in the market are associated with significant bleeding risk and thrombocytopenia. We now have successfully developed a novel antithrombotic drug without these side effects.
Other Products
-
Anti-fibrotic Drug Targeting ECM
-
Modification Platforms for Protein Therapeutics
-
Bispecific Drugs for Cancers
-
Protein Production and GLP Laboratory
-
Fibrin and Platelet-targeting Thrombolytic Drug
Highest Rated Products
-
2ton Mixing and Melting Tank with Storage Tanks
-
Planetary Vacuum Mixer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Pneumatic Liquid Filling Machine
-
High Speed Mixing Machine
-
Powder Machine-High Speed Mixer / Granulator
-
VACUUM EMULSIFY MIXING EQUIPMENT (Bottom Homogenized Series)
-
SEMI-AUTOMATIC EYESHADOW PRESS MACHINE
-
In-Line Homogenizer
-
VACUUM EMULSIFY MIXING EQUIPMENT
-
Steel Basket-Strainer 20µm
-
NK Induction and Expansion Kit
-
PuraLev® SU Low Shear Single-Use Pump Systems
-
ABCcolla® Collagen Bone Graft
-
SOL Count, Lens-free automatic cell counter
-
CDMO
-
Cellabsys - SONICSTEM™ Non-contact Ultrasound device for Tissue Sonication
-
Exodus, Automatic exosome isolation system
-
GMP GLP GDP Life Science Engineering Services
-
WEARABLE STIMULATION DEVICE FOR STIMULATING DEEP MUSCLES OF ABDOMEN AND WAIST OF HUMAN BODY
-
EphA10-Trispecific Antibody of T & NK cell Engager
-
BLOOMNEST™ -Sialic acid
-
Prof. Ting-Wei Wang -- Wearable Pocket-Sized Fully Non-Contact Cardiorespiratory Sensor
-
EDA Low Laser Therapy Devices
-
Cell & Gene and Exosome therapy CDMO
-
ÜberStrainer 1 µm
-
ÜberStrainer 5µm
-
ÜberStrainer 10µm
-
ÜberStrainer 15µm
-
ÜberStrainer 20µm
